kidney diseases

Latest news and articles about kidney diseases from NEX English

Biogen acquires Apellis Pharmaceuticals for $5.6 billion

Biogen, a company specializing in drug development, has announced its acquisition of Apellis Pharmaceuticals for <strong>$5.6 billion</strong>. This move aims to expand Biogen's capabilities in treating kidney diseases, addressing the growing need for effective therapies.

Delay in Diagnosing Rare Kidney Diseases Threatens Patients' Lives

A discussion at the European Health Summit in Brussels revealed common delays in diagnosing rare kidney diseases, negatively impacting patients and their families. New data indicates that early diagnosis can alleviate health and economic burdens.